Literature DB >> 29249450

Perfusion defects in pulmonary perfusion iodine maps: causes and semiology.

A Bustos Fiore1, M González Vázquez2, C Trinidad López2, D Mera Fernández2, M Costas Álvarez2.   

Abstract

OBJECTIVE: to describe the usefulness of dual-energy CT for obtaining pulmonary perfusion maps to provide morphological and functional information in patients with pulmonary embolisms. To review the semiology of perfusion defects due to pulmonary embolism so they can be differentiated from perfusion defects due to other causes: alterations outside the range used in the iodine map caused by other diseases of the lung parenchyma or artifacts.
CONCLUSION: CT angiography of the pulmonary arteries is the technique of choice for the diagnosis of pulmonary embolisms. New dual-energy CT scanners are useful for detecting perfusion defects secondary to complete or partial obstruction of pulmonary arteries and is most useful for detecting pulmonary embolisms in subsegmental branches.
Copyright © 2017 SERAM. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Dual energy; Energía dual; Iodine map; Lung perfusion; Mapa de iodo; Perfusión pulmonar; Pulmonary embolism; Tromboembolismo pulmonar

Mesh:

Substances:

Year:  2017        PMID: 29249450     DOI: 10.1016/j.rx.2017.11.004

Source DB:  PubMed          Journal:  Radiologia (Engl Ed)        ISSN: 2173-5107


  2 in total

1.  Blue Lungs in Covid-19 Patients: A Step beyond the Diagnosis of Pulmonary Thromboembolism using MDCT with Iodine Mapping.

Authors:  Virginia Pérez Dueñas; María Allona Krauel; Emilio Agrela Rojas; Maria Teresa Ramírez Prieto; Laura Díez Izquierdo; Ulpiano López de la Guardia; Isabel Torres Sánchez
Journal:  Arch Bronconeumol       Date:  2020-08-28       Impact factor: 4.872

2.  [Blue Lungs in Covid-19 Patients: A Step beyond the Diagnosis of Pulmonary Thromboembolism using MDCT with Iodine Mapping].

Authors:  Virginia Pérez Dueñas; María Allona Krauel; Emilio Agrela Rojas; Maria Teresa Ramírez Prieto; Laura Díez Izquierdo; Ulpiano López de la Guardia; Isabel Torres Sánchez
Journal:  Arch Bronconeumol       Date:  2020-08-28       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.